Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic
GENEVA, 14 October— The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization’s 2021 Global TB report. In 2020, more people died from TB, with far fewer people being diagnosed and treated or provided […]
Democratic Republic of the Congo starts Ebola vaccination
Brazzaville/Kinshasa, 13 October 2021 – Ebola vaccination began today in the Democratic Republic of the Congo’s North Kivu Province where a case was confirmed on 8 October. People at high risk, including contacts of the confirmed case and first responders will receive the doses as the health authorities move to curb the spread of the […]
WHO calls for better and fairer opportunities for physical activity to improve health
WHO today called on decision-makers across the health, sport, education and transport sectors to urgently scale up provision of more inclusive programmes and services and safer environments that promote physical activity in all communities. The Organization’s new advocacy brief, Fair Play: Building a strong physical activity system for more active people, explains how this can […]
WHO Announces Proposed Members of its Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)
GENEVA - Following a public call for experts, the World Health Organization (WHO) today announced proposed members of the WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO). The SAGO will advise WHO on the development of a global framework to define and guide studies into the origins of emerging and re-emerging pathogens […]
Disease Outbreak News (DON) - Zika Virus Disease - India
On 8 July 2021, a Zika virus (ZIKV) infection was laboratory-confirmed in a resident of Kerala state, south-west India. This represents the first Zika virus disease case ever reported from Kerala. ZIKV viral RNA was detected through RT-PCR testing at the National Institute of Virology (NIV) Pune, in a blood sample collected from the patient, […]
VPC on the launch of the 2021 Global Tuberculosis Report, 14 October
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets. The 2021 edition of the report has been […]
Deparment of Pharmaceuticals to organize a Felicitation Ceremony for winners of ‘Pharma & Medical Devices Startup Grand Challenge’ on 18th October 2021
The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, and Invest India are organizing a Felicitation Ceremony for the winning start-ups of the ‘Pharma & Medical Devices Startup Grand Challenge’ through a video conference on Monday, 18th of October, 2021 from 5:00 p.m. to 6:00 p.m. The felicitation ceremony shall have Shri Amitabh Kant, CEO, […]
Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
35% reduction in risk of needing a walking aid in relapsing multiple sclerosis (RMS) after 7.5 years vs. initiation 2 years later in Phase III open-label extension (OLE) 29% reduction in 48-week confirmed disability progression in primary progressive MS (PPMS) after 8 years vs. initiation after double-blind period in Phase III OLE New 8-year safety […]
Dr Bharati Pravin Pawar launches Phase II of Awareness Campaigns on HIV/AIDS & TB under ‘Azadi ka Amrit Mahotsav’
Dr Bharati Pravin Pawar, Union Minister of State for Health and Family Welfare launched Phase II of awareness campaigns on HIV/AIDS & TB under Azadi ka Amrit Mahotsav, here today. She also virtually interacted with students from across the country and encouraged them to contribute to nation building, as India commemorates 75th year of Independence. […]
Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) Gantenerumab is the first and only anti-amyloid antibody being investigated for subcutaneous administration in late-stage trials for the treatment of AD Ongoing Phase III GRADUATE programme with gantenerumab is anticipated to deliver a comprehensive data set with expected readout in the […]
